182
Active Trials
61
Phase 1
58
Phase 2
73
Phase 3
18
Therapeutic Areas
Portfolio Concentration: 62% of active trials in Oncology
Oncology
112 active / 234 total
Solid Tumor (Advanced)
17 active
2 Ph3
44 total since 2015
Multiple Myeloma
16 active
4 Ph3
25 total since 2015
NSCLC
11 active
4 Ph3
19 total since 2015
Ovarian Cancer
9 active
1 Ph3
13 total since 2015
AML
7 active
3 Ph3
21 total since 2015
CLL
7 active
2 Ph3
12 total since 2015
Colorectal Cancer
7 active
1 Ph3
10 total since 2015
Non-Hodgkin Lymphoma
5 active
14 total since 2015
Esophageal Cancer
4 active
4 total since 2015
Hepatocellular Carcinoma
4 active
1 Ph3
4 total since 2015
SCLC
3 active
1 Ph3
12 total since 2015
Hodgkin Lymphoma
3 active
1 Ph3
5 total since 2015
Triple Negative Breast Cancer
3 active
4 total since 2015
Myelofibrosis
2 active
1 Ph3
5 total since 2015
MDS
2 active
1 Ph3
4 total since 2015
Pancreatic Cancer
2 active
3 total since 2015
Breast Cancer
1 active
4 total since 2015
Head and Neck Cancer
1 active
4 total since 2015
ALL
1 active
1 Ph3
3 total since 2015
Prostate Cancer
1 active
3 total since 2015
Hematologic Malignancies
1 active
3 total since 2015
Gastric Cancer
1 active
2 total since 2015
Endometrial Cancer
1 active
1 total since 2015
Cervical Cancer
1 active
1 total since 2015
Cholangiocarcinoma
1 active
1 total since 2015
Bladder Cancer
1 active
1 total since 2015
Glioblastoma
0 active
6 total since 2015
Sarcoma
0 active
2 total since 2015
Neuroendocrine Tumors
0 active
1 total since 2015
Melanoma
0 active
1 total since 2015
Thyroid Cancer
0 active
1 total since 2015
Brain Tumor
0 active
1 total since 2015
Immunology
45 active / 157 total
Rheumatoid Arthritis
13 active
4 Ph3
41 total since 2015
Ulcerative Colitis
8 active
6 Ph3
20 total since 2015
Crohn's Disease
7 active
6 Ph3
17 total since 2015
Atopic Dermatitis
6 active
4 Ph3
18 total since 2015
Psoriatic Arthritis
4 active
3 Ph3
10 total since 2015
Ankylosing Spondylitis
3 active
2 Ph3
20 total since 2015
Psoriasis
2 active
1 Ph3
25 total since 2015
Lupus
2 active
1 Ph3
5 total since 2015
IBD
0 active
1 total since 2015
CNS
16 active / 89 total
Migraine
10 active
9 Ph3
31 total since 2015
Parkinson's Disease
2 active
2 Ph3
14 total since 2015
Major Depression
2 active
1 Ph3
9 total since 2015
Schizophrenia
1 active
7 total since 2015
Anxiety
1 active
5 total since 2015
Alzheimer's Disease
0 active
9 total since 2015
ALS
0 active
4 total since 2015
Multiple Sclerosis
0 active
4 total since 2015
Autism Spectrum Disorder
0 active
3 total since 2015
Epilepsy
0 active
2 total since 2015
Bipolar Disorder
0 active
1 total since 2015
Ophthalmology
12 active / 36 total
Cardiovascular
7 active / 25 total
Dermatology
5 active / 10 total
Metabolic
2 active / 10 total
Musculoskeletal
2 active / 6 total
Urology
1 active / 13 total
Respiratory
1 active / 6 total
Rare Disease
1 active / 5 total
Women's Health
1 active / 4 total
Endocrine
1 active / 2 total
Infectious Disease
0 active / 47 total
Gastrointestinal
0 active / 8 total
Hepatology
0 active / 3 total
Pain
0 active / 2 total
Renal
0 active / 1 total
Click an indication to see competitive landscape (all sponsors in that indication).
Data: ClinicalTrials.gov (2015+)